ADIPOQ and metabolic disease: The effect of NAOs on HFD-induced obese mice effectively suppressed obesity and metabolic diseases associated with obesity (hyperlipidemia, steatosis, insulin resistance, and glucose intolerance) through increased adiponectin production and regulation of the gut microbiome.